These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 3901990

  • 1. Fansidar for malaria prophylaxis.
    Kissane D.
    Aust Fam Physician; 1985 Aug; 14(8):738. PubMed ID: 3901990
    [No Abstract] [Full Text] [Related]

  • 2. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1985 Jan 04; 33(51-52):713-4. PubMed ID: 3917533
    [No Abstract] [Full Text] [Related]

  • 3. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
    Tan Heng Soon, Tan Puay Eng.
    Med J Malaysia; 1983 Sep 04; 38(3):217-23. PubMed ID: 6369092
    [No Abstract] [Full Text] [Related]

  • 4. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).
    Svanbom M, Rombo L, Gustafsson L.
    Br Med J (Clin Res Ed); 1984 Jun 23; 288(6434):1876. PubMed ID: 6428585
    [No Abstract] [Full Text] [Related]

  • 5. Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
    JAMA; 1985 Jan 25; 253(4):483. PubMed ID: 3881605
    [No Abstract] [Full Text] [Related]

  • 6. [The reliability and side effects of malaria chemoprophylaxis].
    Steffen R, Heusser R.
    Schweiz Rundsch Med Prax; 1986 Apr 15; 75(16):446-8. PubMed ID: 2939527
    [No Abstract] [Full Text] [Related]

  • 7. Boxed warning added to Fansidar labeling.
    FDA Drug Bull; 1985 Aug 15; 15(2):21. PubMed ID: 4054454
    [No Abstract] [Full Text] [Related]

  • 8. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.
    Miller KD, Lobel HO, Satriale RF, Kuritsky JN, Stern R, Campbell CC.
    Am J Trop Med Hyg; 1986 May 15; 35(3):451-8. PubMed ID: 2939735
    [Abstract] [Full Text] [Related]

  • 9. [Eosinophilic lung infiltration during malaria prophylaxis with pyrimethamine-sulfadoxine (Fansidar)].
    Buser P, Räber J.
    Schweiz Med Wochenschr; 1985 Aug 24; 115(34):1174-6. PubMed ID: 4048913
    [Abstract] [Full Text] [Related]

  • 10. Malaria chemoprophylaxis--which drug?
    Biddulph J.
    P N G Med J; 1983 Jun 24; 26(2):127-30. PubMed ID: 6388184
    [No Abstract] [Full Text] [Related]

  • 11. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1985 Apr 12; 34(14):185-90, 195. PubMed ID: 3156271
    [No Abstract] [Full Text] [Related]

  • 12. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
    Hellgren U, Rombo L, Berg B, Carlson J, Wiholm BE.
    Br Med J (Clin Res Ed); 1987 Aug 08; 295(6594):365-6. PubMed ID: 2958104
    [No Abstract] [Full Text] [Related]

  • 13. [Malaria prevention with Fansidar as a cause of Stevens-Johnson syndrome].
    Claréus BW, Hammar H.
    Lakartidningen; 1985 Nov 27; 82(48):4211. PubMed ID: 4079604
    [No Abstract] [Full Text] [Related]

  • 14. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 Jan 17; 35(2):21-22, 27. PubMed ID: 3001495
    [No Abstract] [Full Text] [Related]

  • 15. A case of fansidar-resistant Plasmodium falciparum from Tanzania.
    De Geus A, Meuwissen JH, van Rijn A.
    Trop Geogr Med; 1982 Jan 17; 34(3):261-3. PubMed ID: 6758245
    [No Abstract] [Full Text] [Related]

  • 16. Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).
    Daniel PT, Holzschuh J, Berg PA.
    Thorax; 1989 Apr 17; 44(4):307-9. PubMed ID: 2763233
    [Abstract] [Full Text] [Related]

  • 17. [Stevens-Johnson syndrome and granulopenia induced by sulfadoxine-pyrimethamine (Fansidar)].
    Ligthelm RJ, van Zwienen J, Stuiver PC, Djajadiningrat AP.
    Ned Tijdschr Geneeskd; 1983 Sep 17; 127(38):1735-7. PubMed ID: 6633717
    [No Abstract] [Full Text] [Related]

  • 18. Adverse reactions to Fansidar.
    Kollisch DO.
    J Fam Pract; 1986 Sep 17; 23(3):202-4. PubMed ID: 2943869
    [No Abstract] [Full Text] [Related]

  • 19. Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine/sulfadoxine.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1989 May 26; 38(20):363-4. PubMed ID: 2497333
    [No Abstract] [Full Text] [Related]

  • 20. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP, Wetsteyn JC, Meuwissen JH.
    Trop Geogr Med; 1982 May 26; 34(3):263-5. PubMed ID: 6758246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.